Discovery of a Novel Series of 7-Azaindole Scaffold Derivatives as PI3K Inhibitors with Potent Activity

被引:27
|
作者
Yang, Chengbin [1 ]
Zhang, Xi [2 ]
Wang, Yi [2 ]
Yang, Yongtai [1 ]
Liu, Xiaofeng [1 ]
Deng, Mingli [1 ]
Jia, Yu [1 ]
Ling, Yun [1 ]
Meng, Ling-hua [2 ]
Zhou, Yaming [1 ]
机构
[1] Fudan Univ, Shanghai Key Lab Mol Catalysis & Innovat Mat, Dept Chem, Shanghai 200433, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res, Shanghai 201203, Peoples R China
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2017年 / 8卷 / 08期
关键词
PI3K; PI3K/mTOR; oncology; 1H-pyrrolo[2,3-b] pyridine; cancer therapy; PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS; (PI3K)/MAMMALIAN TARGET; PI3K/AKT/MTOR PATHWAY; ANTITUMOR-ACTIVITY; KINASE INHIBITOR; CANCER-THERAPY; HIGHLY POTENT; RAPAMYCIN; IDENTIFICATION; DESIGN;
D O I
10.1021/acsmedchemlett.7b00222
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The phosphoinositide 3-kinase (PI3K) inhibitors potently inhibit the signaling pathway of PI3K/AKT/mTOR, which provides a promising new approach for the molecularly targeted cancer therapy. In this work, a novel series of 7-azaindole scaffold derivatives was discovered by the fragment-based growing strategy. The structure-activity relationship profiles identified that the 7-azaindole scaffold derivatives exhibit potent activity against PI3K at molecular and cellular levels as well as cell proliferation in a panel of human tumor cells.
引用
收藏
页码:875 / 880
页数:6
相关论文
共 50 条
  • [1] Discovery of Potent and Selective 7-Azaindole Isoindolinone-Based PI3Kγ Inhibitors
    Miles, Dillon H.
    Yan, Xuelei
    Thomas-Tran, Rhiannon
    Fournier, Jeremy
    Sharif, Ehesan U.
    Drew, Samuel L.
    Mata, Guillaume
    Lawson, Kenneth, V
    Ginn, Elaine
    Wong, Kent
    Soni, Divyank
    Dhanota, Puja
    Shaqfeh, Stefan G.
    Meleza, Cesar
    Chen, Ada
    Pham, Amber T.
    Park, Timothy
    Swinarski, Debbie
    Banuelos, Jesus
    Schindler, Ulrike
    Walters, Matthew J.
    Walker, Nigel P.
    Zhao, Xiaoning
    Young, Stephen W.
    Chen, Jie
    Jin, Lixia
    Leleti, Manmohan Reddy
    Powers, Jay P.
    Jeffrey, Jenna L.
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (11): : 2244 - 2252
  • [2] Discovery of novel quinazolinone derivatives as high potent and selective PI3Kδ and PI3Kδ/γ inhibitors
    Ma, Chen-Chen
    Zhang, Cheng-Mei
    Tang, Long-Qian
    Liu, Zhao-Peng
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 151 : 9 - 17
  • [3] Discovery of cinnoline derivatives as potent PI3K inhibitors with antiproliferative activity
    Tian, Chengze
    Yang, Chengbin
    Wu, Tianze
    Lu, Mingzhu
    Chen, Yi
    Yang, Yongtai
    Liu, Xiaofeng
    Ling, Yun
    Deng, Mingli
    Jia, Yu
    Zhou, Yaming
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 48
  • [4] Discovery of a Novel Series of Thienopyrimidine as Highly Potent and Selective PI3K Inhibitors
    Han, Fangbin
    Lin, Songwen
    Liu, Peng
    Liu, Xiujie
    Tao, Jing
    Deng, Xiaobing
    Yi, Chongqin
    Xu, Heng
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (04): : 434 - 438
  • [5] Discovery of novel quinazoline derivatives as potent PI3Kδ inhibitors with high selectivity
    Teng, Yu
    Li, Xinyu
    Ren, Shengnan
    Cheng, Yu
    Xi, Kun
    Shen, Hongtao
    Ma, Wenzhuo
    Luo, Guoshun
    Xiang, Hua
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 208
  • [6] Discovery of fluoroquinolone derivatives as potent, selective inhibitors of PI3Kγ
    Sha, Shao
    Han, Hong-Wei
    Gao, Fei
    Liu, Tian-Bao
    Li, Zhen
    Xu, Chi
    Zhong, Wei-Qing
    Zhu, Hai-Liang
    [J]. MEDCHEMCOMM, 2015, 6 (11) : 2029 - 2035
  • [7] Discovery of 7-azaindole derivatives as potent Orai inhibitors showing efficacy in a preclinical model of asthma
    Esteve, Cristina
    Gonzalez, Jacob
    Gual, Silvia
    Vidal, Laura
    Alzina, Soledad
    Sentellas, Sonia
    Jover, Irene
    Horrillo, Raquel
    De Alba, Jorge
    Miralpeix, Montserrat
    Tarrason, Gema
    Vidal, Bernat
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (06) : 1217 - 1222
  • [8] Discovery of a Novel Series of Potent and Selective Alkynylthiazole-Derived PI3Kγ Inhibitors
    Bandarage, Upul K.
    Aronov, Alex M.
    Cao, Jingrong
    Come, Jon H.
    Cottrell, Kevin M.
    Davies, Robert J.
    Giroux, Simon
    Jacobs, Marc
    Mahajan, Sudipta
    Messersmith, David
    Moody, Cameron S.
    Swett, Rebecca
    Xu, Jinwang
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (01): : 129 - 135
  • [9] Development of anti-breast cancer PI3K inhibitors based on 7-azaindole derivatives through scaffold hopping: Design, synthesis and in vitro biological evaluation
    Yang, Chengbin
    Lu, Mingzhu
    Chen, Yi
    Xiang, Ruiqing
    Qiu, Tianze
    Jia, Yu
    Yang, Yongtai
    Liu, Xiaofeng
    Deng, Mingli
    Ling, Yun
    Zhou, Yaming
    [J]. BIOORGANIC CHEMISTRY, 2021, 117
  • [10] Discovery of Potent and Selective PI3Kγ Inhibitors
    Drew, Samuel L.
    Thomas-Tran, Rhiannon
    Beatty, Joel W.
    Fournier, Jeremy
    Lawson, Kenneth, V
    Miles, Dillon H.
    Mata, Guillaume
    Sharif, Ehesan U.
    Yan, Xuelei
    Mailyan, Artur K.
    Ginn, Elaine
    Chen, Jie
    Wong, Kent
    Soni, Divyank
    Dhanota, Puja
    Chen, Pei-Yu
    Shaqfeh, Stefan G.
    Meleza, Cesar
    Pham, Amber T.
    Chen, Ada
    Zhao, Xiaoning
    Banuelos, Jesus
    Jin, Lixia
    Schindler, Ulrike
    Walters, Matthew J.
    Young, Stephen W.
    Walker, Nigel P.
    Leleti, Manmohan Reddy
    Powers, Jay P.
    Jeffrey, Jenna L.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (19) : 11235 - 11257